Xolair 300 MG/2 ML syringe 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FGEN9
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,785
Award facts
- Contract value 100% obligated
- $22,784.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $22.8K to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Xolair 300 mg/2 mL syringes. The award, issued on November 26, 2025, with a completion date of December 18, 2025, uses firm fixed-price pricing with no set-aside designation. This delivery order was issued under DMS Pharmaceutical Group's recently awarded Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) Indefinite Delivery Contract, which carries a $500M ceiling and extends through December 31, 2036.
The PPV-G GEN V represents a $30.3 billion federal pharmaceutical supply initiative designed to support recurring medical supply needs across Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group's selection as a prime vendor contractor positions the company to deliver a comprehensive portfolio of branded and generic pharmaceuticals, biologics, vaccines, and medical consumables to military medical systems globally. As an established performer on the DLA Medical Supply Chain, the company has demonstrated consistent capability across diverse therapeutic categories, supporting critical defense healthcare operations through efficient pharmaceutical distribution and supply chain management.
Quick answers
Who was awarded contract SPE2DR26FGEN9?
SPE2DR26FGEN9 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 26, 2025.
How much is contract SPE2DR26FGEN9 worth?
The government has obligated $22,785 on SPE2DR26FGEN9.
Is contract SPE2DR26FGEN9 an order under another contract?
Yes. SPE2DR26FGEN9 is a delivery order under SPE2DR25D9312, an indefinite delivery contract.
Was contract SPE2DR26FGEN9 competed?
The extent of competition for SPE2DR26FGEN9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award